cD24 isoform a promotes cell proliferation, migration and invasion and is downregulated by egr1 in hepatocellular carcinoma

of hepatocellular carcinoma (HCC). However, little is known about the expression and function of CD24 isoform a (CD24A) and CD24 isoform b (CD24B) in HCC. Materials and methods: Quantitative real-time polymerase chain reaction (qPCR) and Western blotting were performed to detect CD24 and EGR1 expression in HCC cells and tissue. The function of CD24 in cell proliferation was verified with MTT assays, colony formation assays and tumor xenograft models. Wound healing assays and invasion assays were performed to clarify the function of CD24 in the regulation of cell migration and invasion in HCC. A dual luciferase reporter assay and chromatin immunoprecipitation assay were used to analyze the regulation mechanism of CD24A. Results: CD24A but not CD24B, which was barely detected by qPCR and Western blotting, is significantly upregulated in HCC tissue. Both CD24A and CD24B contribute to HCC cell proliferation, migration and invasion, but CD24A is more effective than CD24B. EGR1 downregulates CD24A and exerts transcription-promoting activity on the CD24A promoter. Furthermore, EGR1 represses HCC cell proliferation via downregulation of CD24A. Conclusion: CD24A is the predominant CD24 isoform in HCC and plays a major role in cell proliferation, migration, and invasion. EGR1 can exert its antitumor effect through transcriptional downregulation of CD24A in HCC.

[1]  Erratum: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. , 2020, CA: a cancer journal for clinicians.

[2]  M. Bandehpour,et al.  Overview of CD24 as a new molecular marker in ovarian cancer , 2018, Journal of cellular physiology.

[3]  L. Bian,et al.  CD44+/CD24+-Expressing Cervical Cancer Cells and Radioresistant Cervical Cancer Cells Exhibit Cancer Stem Cell Characteristics , 2018, Gynecologic and Obstetric Investigation.

[4]  T. Billiar,et al.  iNOS promotes CD24+CD133+ liver cancer stem cell phenotype through a TACE/ADAM17-dependent Notch signaling pathway , 2018, Proceedings of the National Academy of Sciences.

[5]  M. Hoque,et al.  CD24 regulates cancer stem cell (CSC)-like traits and a panel of CSC-related molecules serves as a non-invasive urinary biomarker for the detection of bladder cancer , 2018, British Journal of Cancer.

[6]  Lei Liu,et al.  EGR1-Mediated Transcription of lncRNA-HNF1A-AS1 Promotes Cell-Cycle Progression in Gastric Cancer. , 2018, Cancer research.

[7]  J. Llovet,et al.  Molecular therapies and precision medicine for hepatocellular carcinoma , 2018, Nature Reviews Clinical Oncology.

[8]  R. Jiang,et al.  CD24 regulates sorafenib resistance via activating autophagy in hepatocellular carcinoma , 2018, Cell Death & Disease.

[9]  Jie Xu,et al.  CD24 Overexpression Related to Lymph Node Invasion and Poor Prognosis of Colorectal Cancer. , 2018, Clinical laboratory.

[10]  Min Liu,et al.  miR-3928v is induced by HBx via NF-κB/EGR1 and contributes to hepatocellular carcinoma malignancy by down-regulating VDAC3 , 2018, Journal of Experimental & Clinical Cancer Research.

[11]  M. Saito,et al.  Downregulation of CD24 suppresses bone metastasis of lung cancer , 2017, Cancer science.

[12]  Jinjun Li,et al.  NK3 homeobox 1 (NKX3.1) up-regulates forkhead box O1 expression in hepatocellular carcinoma and thereby suppresses tumor proliferation and invasion , 2017, The Journal of Biological Chemistry.

[13]  J. Pruszak,et al.  The CD24 surface antigen in neural development and disease , 2017, Neurobiology of Disease.

[14]  Ming Sun,et al.  The Pseudogene DUXAP8 Promotes Non-small-cell Lung Cancer Cell Proliferation and Invasion by Epigenetically Silencing EGR1 and RHOB. , 2017, Molecular therapy : the journal of the American Society of Gene Therapy.

[15]  Tingtao Chen,et al.  Hedgehog signaling pathway regulates ovarian cancer invasion and migration via adhesion molecule CD24 , 2017, Journal of Cancer.

[16]  A. Fujimura,et al.  CD24 Modulates Chemosensitivity of MCF-7 Breast Cancer Cells. , 2017, Anticancer research.

[17]  G. Sonpavde,et al.  CD24 is a genetic modifier for risk and progression of prostate cancer , 2017, Molecular carcinogenesis.

[18]  Garrett M. Dancik,et al.  GON4L Drives Cancer Growth through a YY1-Androgen Receptor-CD24 Axis. , 2016, Cancer research.

[19]  T. Song,et al.  EGR1 mediates miR-203a suppress the hepatocellular carcinoma cells progression by targeting HOXD3 through EGFR signaling pathway , 2016, Oncotarget.

[20]  L. Bian,et al.  CD44+/CD24+ cervical cancer cells resist radiotherapy and exhibit properties of cancer stem cells. , 2016, European review for medical and pharmacological sciences.

[21]  Yun Chen,et al.  CD24 promotes HCC progression via triggering Notch-related EMT and modulation of tumor microenvironment , 2016, Tumor Biology.

[22]  Wei Zhang,et al.  Silencing of CD24 Enhances the PRIMA-1–Induced Restoration of Mutant p53 in Prostate Cancer Cells , 2015, Clinical Cancer Research.

[23]  G. Kristiansen,et al.  Membranous CD24 expression as detected by the monoclonal antibody SWA11 is a prognostic marker in non-small cell lung cancer patients , 2015, BMC Clinical Pathology.

[24]  Kathleen R. Cho,et al.  CD24+ Ovarian Cancer Cells Are Enriched for Cancer-Initiating Cells and Dependent on JAK2 Signaling for Growth and Metastasis , 2015, Molecular Cancer Therapeutics.

[25]  Bing Li,et al.  Combined aberrant expression of N-Myc downstream-regulated gene 2 and CD24 is associated with disease-free survival and overall survival in patients with hepatocellular carcinoma , 2014, Diagnostic Pathology.

[26]  N. Arber,et al.  CD24 knockout prevents colorectal cancer in chemically induced colon carcinogenesis and in APCMin/CD24 double knockout transgenic mice , 2014, International journal of cancer.

[27]  Gui-yuan Li,et al.  Egr-1 regulates the transcription of NGX6 gene through a Sp1/Egr-1 overlapping site in the promoter , 2014, BMC Molecular Biology.

[28]  Su-Hyung Hong,et al.  EGR1-dependent PTEN upregulation by 2-benzoyloxycinnamaldehyde attenuates cell invasion and EMT in colon cancer. , 2014, Cancer letters.

[29]  Xavier Robert,et al.  Deciphering key features in protein structures with the new ENDscript server , 2014, Nucleic Acids Res..

[30]  Haiyang Xie,et al.  Ribonucleotide reductase M2B inhibits cell migration and spreading by early growth response protein 1‐mediated phosphatase and tensin homolog/Akt1 pathway in hepatocellular carcinoma , 2014, Hepatology.

[31]  Ying-chao Wang,et al.  CD24 mediates gastric carcinogenesis and promotes gastric cancer progression via STAT3 activation , 2014, Apoptosis.

[32]  Shuyong Lin,et al.  Twist2 promotes self-renewal of liver cancer stem-like cells by regulating CD24. , 2014, Carcinogenesis.

[33]  P. Leung,et al.  Egr-1 mediates epidermal growth factor-induced downregulation of E-cadherin expression via Slug in human ovarian cancer cells , 2013, Oncogene.

[34]  G. Smith,et al.  Highly sensitive profiling of CD44+/CD24- breast cancer stem cells by combining global mRNA amplification and next generation sequencing: evidence for a hyperactive PI3K pathway. , 2012, Cancer letters.

[35]  E. Erdal,et al.  Heparin Inhibits Hepatocyte Growth Factor Induced Motility and Invasion of Hepatocellular Carcinoma Cells through Early Growth Response Protein 1 , 2012, PloS one.

[36]  D. Simeone,et al.  Identification of glycoprotein markers for pancreatic cancer CD24+CD44+ stem-like cells using nano-LC-MS/MS and tissue microarray. , 2012, Journal of proteome research.

[37]  Huan Yang,et al.  Identification of CD44+CD24+ gastric cancer stem cells , 2011, Journal of Cancer Research and Clinical Oncology.

[38]  I. Ng,et al.  CD24(+) liver tumor-initiating cells drive self-renewal and tumor initiation through STAT3-mediated NANOG regulation. , 2011, Cell stem cell.

[39]  Tong Wu,et al.  Microsomal prostaglandin E synthase-1 (mPGES-1) promotes hepatocarcinogenesis through activation of a novel EGR1/β-catenin signaling axis , 2011, Oncogene.

[40]  Byoung-Gie Kim,et al.  Prognostic significance of CD24 protein expression in patients treated with adjuvant radiotherapy after radical hysterectomy for cervical squamous cell carcinoma. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[41]  N. Cho,et al.  CD24+ cells from hierarchically organized ovarian cancer are enriched in cancer stem cells , 2010, Oncogene.

[42]  J. Alcocer-Varela,et al.  Early growth response transcription factors and the modulation of immune response: implications towards autoimmunity. , 2010, Autoimmunity reviews.

[43]  W. Bodmer,et al.  Cancer stem cells from colorectal cancer-derived cell lines , 2010, Proceedings of the National Academy of Sciences.

[44]  S. Qiu,et al.  CD24 Is a Novel Predictor for Poor Prognosis of Hepatocellular Carcinoma after Surgery , 2009, Clinical Cancer Research.

[45]  A. Ristimäki,et al.  Tissue-specific promoters active in CD44+CD24-/low breast cancer cells. , 2008, Cancer research.

[46]  G. Christofori,et al.  Hepatocyte growth factor induces cell scattering through MAPK/Egr‐1‐mediated upregulation of Snail , 2006, The EMBO journal.

[47]  S. Thorgeirsson,et al.  Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling , 2004, Hepatology.

[48]  C. Pilarsky,et al.  CD24 expression is a new prognostic marker in breast cancer. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[49]  S. Morrison,et al.  Prospective identification of tumorigenic breast cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[50]  I. Petersen,et al.  CD24 is an independent prognostic marker of survival in nonsmall cell lung cancer patients , 2003, British Journal of Cancer.

[51]  D. Nathans,et al.  DNA binding site of the growth factor-inducible protein Zif268. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[52]  A. Jemal,et al.  Cancer statistics, 2018 , 2018, CA: a cancer journal for clinicians.

[53]  F. Du,et al.  Egr-1 promotes hypoxia-induced autophagy to enhance chemo-resistance of hepatocellular carcinoma cells. , 2016, Experimental cell research.

[54]  R. Qin,et al.  Isolation and characterization of tumorigenic extrahepatic cholangiocarcinoma cells with stem cell‐like properties , 2011, International journal of cancer.

[55]  M. Clarke,et al.  Identification of pancreatic cancer stem cells. , 2007, Cancer research.